Spectrum: Local Antimicrobial Stewardship, for Saskatchewan Health Authority - Saskatoon Area

Escherichia coli - Antibiogram Data

Inpatients
% of Isolates Susceptible

Antibiogram
Meropenem100%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ertapenem100%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Piperacillin-tazobactam98%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Nitrofurantoin97%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ciprofloxacin97%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Cefoxitin95%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Tobramycin93%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Gentamicin88%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Amoxicillin-clavulanate83%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Trimethoprim-Sulfamethoxazole76%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ceftriaxone55%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ceftazidime54%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Cefazolin50%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Amoxicillin36%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ampicillin36%
n = 95

4.4% of combined E.coli, K.pneumoniae and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Note

  • January 1, 2018 - December 31, 2018

  • R: Intrinsically resistant or less than 25% empiric susceptibility